BriaCell Therapeutics Corp. (BCTXW) Earnings History
Net Loss20 years of earnings data (2006–2025) · Currently unprofitable on a TTM basis
Loading earnings history...
BriaCell Therapeutics Corp. (BCTXW) Earnings Overview
As of June 30, 2026, BriaCell Therapeutics Corp. (BCTXW) reported trailing twelve-month net income of -$26M, reflecting -45.6% year-over-year growth. The company earned $-13.93 per diluted share over the past four quarters.
Looking at the long-term picture, BCTXW's historical earnings data spans multiple years. The company achieved its highest annual net income of $1M in fiscal 2020.
BriaCell Therapeutics Corp. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including NKTR (-$158M net income, -297.1% margin), IMVT (-$506M net income), ADCT (-$137M net income, -175.3% margin), BCTXW has comparable earnings metrics. Compare BCTXW vs NKTR →
BCTXW Earnings vs Peers
Earnings metrics vs comparable public companies
BCTXW Historical Earnings Data (2006–2025)
20 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$26M | -461.6% | -$27M | $-62.60 | - | - |
| 2024 | -$5M | +76.8% | -$33M | $-42.99 | - | - |
| 2023 | -$20M | -75.3% | -$23M | $-1.74 | - | - |
| 2022 | -$12M | -300.0% | -$15M | $-1.73 | - | - |
| 2021 | -$3M | -309.0% | -$7M | $-0.19 | - | - |
| 2020 | $1M | +129.8% | -$4M | $-5.64 | - | - |
| 2019 | $602,680 | -43.4% | $946,423 | $1.04 | - | - |
| 2018 | $1M | +141.2% | -$4M | $2.49 | - | - |
| 2017 | -$3M | -52.4% | -$3M | $-7.32 | - | - |
| 2016 | -$2M | +36.8% | -$2M | $-5.88 | - | - |
| 2015 | -$3M | +67.1% | -$1M | $-10.76 | - | - |
| 2014 | -$8M | -2109.5% | $-437,275 | $-138.07 | - | - |
| 2013 | $-368,695 | +63.0% | $-424,257 | $-6.25 | - | - |
| 2012 | $-995,724 | +7.7% | -$1M | $-16.93 | - | - |
| 2011 | -$1M | -19.8% | -$1M | $-33.02 | - | - |
| 2010 | $-900,738 | -293.7% | $-324,569 | $-49.58 | - | - |
| 2009 | $-228,812 | -131.3% | $-233,872 | $-25.62 | - | - |
| 2008 | $-98,927 | +14.7% | $-114,124 | $-20.45 | - | - |
| 2007 | $-116,000 | -1251.8% | $-129,000 | $-27.92 | - | - |
| 2006 | $-8,581 | - | $-8,581 | $-0.00 | - | - |
Download Data
Export BCTXW earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
20+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
BCTXW — Frequently Asked Questions
Quick answers to the most common questions about buying BCTXW stock.
What is BCTXW earnings per share (EPS)?
BCTXW trailing twelve-month (TTM) diluted EPS is $-13.93, reflecting -45.6% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2006 to 2025 is available in the table on this page.
What is BriaCell Therapeutics Corp.'s net income?
BriaCell Therapeutics Corp. (BCTXW) trailing twelve-month net income is $-26M as of 2025. Earnings declined -45.6% year-over-year.
Is BCTXW profitable?
BCTXW is not currently profitable on a TTM basis, reporting a net loss of $-26M. Net margin is N/A. Investors should monitor for a return to profitability.
What is BCTXW's earnings growth rate?
BCTXW compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2006 to 2025.
What are BCTXW's profit margins?
BriaCell Therapeutics Corp. net profit margin is N/A, operating margin is N/A, and gross margin is N/A. Below-average margins reflect competitive or cost pressures. Return on Equity is -375.6%.
Is BCTXW growing earnings?
BCTXW earnings are declining — EPS fell -45.6% year-over-year. TTM net income dropped to $-26M. This contrasts with the 5-year CAGR of N/A.
What was BCTXW's best earnings year?
BriaCell Therapeutics Corp.'s highest annual net income on record is $1M, achieved in fiscal year 2020. Earnings history on this page spans 2006 to 2025 and includes all annual and quarterly figures.
What were BCTXW's earnings last quarter?
BCTXW's most recent reported quarter was Q4 2025. Net income was $-8M with diluted EPS of $-4.26. For a full breakdown of all quarters, see the quarterly earnings table on this page.